Monika Dudzisz‐Śledź

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

Anna M. Czarnecka, Paweł Teterycz, Anna Mariuk-Jarema et al. · Targeted Oncology · 2019 · 24 citations

Oncology, Melanoma, Pathology +8

Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis

Mateusz Spałek, Jan Poleszczuk, Anna M. Czarnecka et al. · Cells · 2021 · 17 citations · Full text

Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”

Patrick Schöffski, Maud Toulmonde, Anna Estival et al. · European Journal of Cancer · 2021 · 15 citations · Full text

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence

Anna M. Czarnecka, Paweł Sobczuk, Paweł Rogala et al. · Cancer Immunology Immunotherapy · 2022 · 15 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +11

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study

Monika Słowińska, Monika Dudzisz‐Śledź, Paweł Sobczuk et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 15 citations · Full text